Maintenance therapy in chronic lymphocytic leukaemia

被引：0
作者：
Delgado, Julio [1 ]
Montserrat, Emili [1 ]
机构：
[1] Univ Barcelona, Hosp Clin, Inst Haematol & Oncol, Dept Haematol, E-08036 Barcelona, Spain
来源：
LANCET HAEMATOLOGY | 2016年 / 3卷 / 09期
关键词：
RITUXIMAB; CHEMOIMMUNOTHERAPY; LENALIDOMIDE; TRIAL;
D O I：
10.1016/S2352-3026(16)30081-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E399 / E400
页数：2
相关论文
共 50 条
  • [41] Pentostatin and Rituximab Therapy for Previously Untreated Patients With B-Cell Chronic Lymphocytic Leukemia
    Kay, Neil E.
    Wu, Wenting
    Kabat, Brian
    LaPlant, Betsy
    Lin, Thomas S.
    Byrd, John C.
    Jelinek, Diane F.
    Greyer, Michael R.
    Zent, Clive S.
    Call, Timothy G.
    Shanafelt, Tait D.
    CANCER, 2010, 116 (09) : 2180 - 2187
  • [42] Lenalidomide maintenance therapy in previously treated chronic lymphocytic leukaemia (CONTINUUM): a randomised, double-blind, placebo-controlled, phase 3 trial
    Chanan-Khan, Asher A.
    Zaritskey, Andrey
    Egyed, Miklos
    Vokurka, Samuel
    Semochkin, Sergey
    Schuh, Anna
    Kassis, Jeannine
    Simpson, David
    Zhang, Jennie
    Purse, Brendan
    Foa, Robin
    LANCET HAEMATOLOGY, 2017, 4 (11): : E534 - E543
  • [43] A case of paraneoplastic pemphigus associated with chronic lymphocytic leukaemia
    Alband, Neda
    Hayes, Catriona
    McDonald, Sarah
    Ha, Thomas
    Follows, George
    Haque Hussain, Shaheen
    EUROPEAN JOURNAL OF DERMATOLOGY, 2022, 32 (01) : 150 - 153
  • [44] Chronic lymphocytic leukaemia-moving towards cure?
    Hillmen, Peter
    LANCET, 2010, 376 (9747) : 1122 - 1124
  • [45] Expert consensus on the management of chronic lymphocytic leukaemia in Asia
    Tse, Eric
    Kwong, Yok Lam
    Goh, Yeow Tee
    Bee, Ping Chong
    Ng, Soo Chin
    Tan, Daryl
    Caguioa, Priscilla
    Nghia, Huynh
    Dumagay, Teresita
    Norasetthada, Lalita
    Chuncharunee, Suporn
    Radhakrishnan, Vivek
    Bagal, Bhausaheb
    Atmakusuma, Tubagus Djumhana
    Mulansari, Nadia Ayu
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (06) : 2895 - 2907
  • [46] Chronic Lymphocytic Leukaemia in 2020: the Future Has Arrived
    Kate Milne
    Beattie Sturrock
    Timothy Chevassut
    Current Oncology Reports, 2020, 22
  • [47] Novel pathway inhibitors for the treatment of chronic lymphocytic leukaemia
    Molica, Stefano
    Montserrat, Emili
    LANCET HAEMATOLOGY, 2019, 6 (02): : E65 - E66
  • [48] Rituximab in Lymphoma and Chronic Lymphocytic Leukaemia: A Practice Guideline
    Prica, A.
    Baldassarre, F.
    Hicks, L. K.
    Imrie, K.
    Kouroukis, T.
    Cheung, M.
    CLINICAL ONCOLOGY, 2017, 29 (01) : E13 - E28
  • [49] Outcome of patients aged 80 years or older treated for chronic lymphocytic leukaemia
    Al-Sawaf, Othman
    Bahlo, Jasmin
    Robrecht, Sandra
    Fischer, Kirsten
    Herling, Carmen D.
    Hoechstetter, Manuela
    Fink, Anna-Maria
    von Tresckow, Julia
    Langerbeins, Petra
    Cramer, Paula
    Stilgenbauer, Stephan
    Wendtner, Clemens M.
    Eichhorst, Barbara
    Hallek, Michael
    Goede, Valentin
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (05) : 727 - 735
  • [50] Chronic lymphocytic leukaemia Australasian consensus practice statement
    Anderson, Mary A.
    Bennett, Rory
    Badoux, Xavier
    Best, Giles
    Chia, Nicole
    Cochrane, Tara
    Cull, Gavin
    Crassini, Kyle
    Harrup, Rosemary
    Jackson, Sharon
    Kuss, Bryone
    Lasica, Masa
    Lew, Thomas E.
    Marlton, Paula
    Opat, Stephen
    Palfreyman, Emma
    Polizzotto, Mark N.
    Ratnasingam, Sumita
    Seymour, John F.
    Soosapilla, Asha
    Talaulikar, Dipti
    Tam, Constantine S.
    Weinkove, Robert
    Wight, Joel
    Mulligan, Stephen P.
    INTERNAL MEDICINE JOURNAL, 2023, 53 (09) : 1678 - 1691
12345